Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
06/2006
06/29/2006US20060142609 Method of producing nitrile compounds from ethylenically-unsaturated compounds
06/29/2006US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/29/2006US20060142392 Process for preparing (2s)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid derivatives
06/29/2006US20060142389 Pharmaceutically useful salts of carboxylic acid derivatives
06/29/2006US20060142244 Geranyl compounds
06/29/2006CA2592382A1 Modulator
06/29/2006CA2591800A1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists
06/28/2006EP1268405B1 Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents
06/27/2006US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses
06/27/2006US7067542 Diaminediols for the treatment of Alzheimer's disease
06/27/2006US7067119 Using polypeptides
06/22/2006WO2006065214A1 Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid
06/22/2006WO2006063999A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
06/22/2006WO2006063821A1 Manufacture process of n-substituted salicylamides
06/22/2006WO2006063697A1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
06/22/2006US20060135770 PARP inhibitors
06/22/2006US20060135620 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
06/22/2006US20060135614 Novel compounds
06/22/2006US20060135613 Carboxamides derivatives
06/22/2006US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid
06/22/2006US20060134724 Method and probe for identifying bacterial virulence modifying agents, agents thus identifed, and their use
06/22/2006US20060134130 Oral drug delivery compositions and methods
06/22/2006CA2590330A1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
06/22/2006CA2589519A1 Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid
06/22/2006CA2589495A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
06/22/2006CA2587428A1 Manufacture process of organic compounds
06/22/2006CA2587213A1 Manufacture process of n-substituted salicylamides
06/21/2006EP1672055A1 Detergent compositions and processes for the production thereof
06/21/2006EP1671961A1 Cinnamoyl compound and use of the same
06/21/2006EP1671948A1 Cinnamoyl compound and use of the same
06/21/2006EP1670849A1 Aspartate derivatives and process for their preparation
06/21/2006EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists
06/21/2006EP1556436B1 Polyamine derivatives, a process to make them, and their use
06/21/2006EP1100770B1 Monomers and network polymers obtained therefrom
06/21/2006EP1049662B1 Inhibitors of alpha4 mediated cell adhesion
06/21/2006CN1791572A Novel compounds
06/21/2006CN1791568A Hsp90 family protein inhibitors
06/21/2006CN1789283A Artificial antigen, antibody of fenvalerate and uses thereof
06/21/2006CN1789238A Cyfluthrin hapten compound, its synthesis method and use
06/20/2006US7064124 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example
06/15/2006WO2006062093A1 Novel anthranilic acid derivative or salt thereof
06/15/2006US20060128948 obtained by modifying carboxyl groups of biological low-molecular-weight compounds having two or more carboxyl groups with N-hydroxysuccinimide, N-hydroxysulfosuccinimide; used to treat medical devices and the like are non-natural, artificially synthesized products; low toxicity and easily assimilated
06/15/2006US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists
06/15/2006US20060128670 Pesticidally active ketone and oxime derivatives
06/15/2006CA2588633A1 Novel anthranilic acid derivative or salt thereof
06/14/2006EP1667959A1 Biphenyloxy-acids
06/14/2006EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor
06/14/2006EP1102742B1 Compounds and compositions for delivering active agents
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/13/2006US7060700 Amide derivatives useful as inhibitors of the production of cytokines
06/13/2006CA2219278C Methods of making (s)-3-(aminomethyl)-5-methylhexanoic acid
06/08/2006WO2006060800A1 Synthesis of aniline and phenol-based antioxidant macromonomers and corresponding polymers
06/08/2006WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
06/08/2006US20060122429 Preparation of optically active amines
06/08/2006US20060122411 Chloride channel opener
06/08/2006US20060122280 Muscarinic agonists
06/08/2006US20060122257 Phenyl substituted carboxylic acids
06/08/2006US20060122243 Antiallergic
06/08/2006US20060122065 Amide compound and method of controlling plant disease with the same
06/08/2006US20060121583 New method for synthesizing ceramide-type compounds
06/08/2006DE102004057995A1 Verfahren zur Herstellung von α,α-Dialkyl-α-Hydroxymethyl-Carbonsäurederivaten A process for preparing α, α-dialkyl-α-hydroxymethyl-carboxylic acid derivatives
06/08/2006CA2589883A1 Synthesis of aniline and phenol-based antioxidant macromonomers and corresponding polymers
06/07/2006EP1666447A1 Process for the preparation of alpha, alpha-dialkyl, alpha-hydroxymethyl-carboxylic acid derivatives
06/07/2006EP1664316A1 Polyethyleneglycol-modified lipid compounds and uses thereof
06/07/2006EP1663979A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
06/07/2006EP1663953A1 Inhibitors of histone deacetylase
06/07/2006CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
06/07/2006CN1258521C Method for preparing 2 methyl 4 chlorine artificial half antigen, artificial antigen, specific antibody and application
06/06/2006US7057061 Chiral monophosphorus compounds
06/06/2006US7056902 4-dedimethylamino tetracycline compounds
06/06/2006US7056493 Radio-opaque polymer biomaterials
06/01/2006WO2006057869A1 Potentiators of glutamate receptors
06/01/2006WO2006057868A1 Antithrombotic diamides
06/01/2006US20060116424 Using compounds such as [4-[(N,N-diethylcarbamoyl)methoxy]-3-ethoxyphenyl]acetic acid propyl ester for inducing or maintaining anesthesia or sedation
05/2006
05/31/2006EP1661882A1 Compound having anti-hcv activity and process for producing the same
05/31/2006EP1660859A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
05/31/2006EP1660439A2 Aryl and heteroaryl compounds, compositions, and methods of use
05/31/2006EP1659881A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
05/31/2006EP1341743B1 Organic reactions with co generating materials
05/31/2006EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/31/2006CN1257886C Dehydroamino acids compounds
05/30/2006US7053245 N-acylamino benzyl ether derivatives
05/30/2006US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides
05/30/2006US7053127 Aqueous composition contains a piperazonium salt and an alcohol; used in oil field, forming a gel aqueous solution for treating a well drilling in a subterranean formation at high temperature; 1,1-dimethylpiperazino-4-oleylamide ammonium chloride; heat resistance, use less concentration, efficiency
05/30/2006US7053071 Induction of apoptosis in cancer cells
05/30/2006CA2161246C Fullerene derivatives, methods of preparing them and their use
05/26/2006WO2006002361A3 2-methylpropanamides and their use as pharmaceuticals
05/25/2006US20060111406 Amide linker peroxisome proliferator activated receptor modulators
05/25/2006US20060111339 Novel oral general anesthetics and metabolitically resistant anticonvulsants
05/25/2006US20060110743 Drug evolution: drug design at hot spots
05/25/2006US20060110438 Liposome stabilizing agent
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/24/2006CN1777812A Modulators of the G protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
05/24/2006CN1775806A 2, 4, 6-trichlorophen artificial antigen, and its preparing method and use
05/24/2006CN1257153C Novel propargylether derivatives
05/24/2006CN1257152C Short-acting sedative hypnotic agents for anesthesia and sedation
05/23/2006US7049342 Substituted phenylpropionic acid derivatives
05/23/2006US7049338 Antiproliferative agents
05/23/2006CA2194948C Novel aspartylamide derivatives and sweeteners
05/18/2006WO2006051808A1 Hsp90 FAMILY PROTEIN INHIBITORS
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 157